Ovid Therapeutics Inc (NASDAQ:OVID)
| 2.58 Delayed Data As of Mar 31 |  -0.01 / -0.39%Today’s Change | 1.41 Today|||52-Week Range 3.35 | +38.71% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 69.9M | 51.9M | 87.1M | 36.5M | |
| Short Term Investment Cash | 65.1M | -18.0M | 35.2M | -50.6M | ||
| Cash & Short Term Investments | 69.9M | 51.9M | 87.1M | 41.5M | ||
| Receivables | Receivables | 58.6K | 7.4K | 0.00 | 0.00 | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 280.3K | 221.5K | 1.5M | 2.8M | |
| Current Assets | 70.3M | 52.2M | 88.6M | 44.3M | ||
| Total Assets | Property, Plant and Equipment - Gross | 33.4K | 63.8K | 102.7K | 156.0K | |
| Depreciation | -3.9K | -20.2K | -50.9K | -86.2K | ||
| Intangible Assets | 18.9K | 110.1K | 124.2K | 391.9K | ||
| Other Assets | 63.7K | 815.8K | 817.8K | 3.3M | ||
| Total Assets | 70.4M | 53.0M | 89.5M | 47.6M | ||
| Liabilities | Accounts Payable | 670.5K | 857.2K | 2.0M | 3.8M | |
| Accrued Expenses | 1.6M | 2.9M | 2.1M | 2.3M | ||
| Other Current Liabilities | 1.6M | 2.9M | 2.1M | 2.3M | ||
| Other Liabilities | 2.3M | 3.7M | 6.0M | 8.8M | ||
| Total Liabilities | Total Liabilities | 2.3M | 3.7M | 6.0M | 8.8M | |
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 8.0K | 8.0K | 0.00 | 0.00 | ||
| Common Equity | 68.1M | 49.3M | 83.4M | 38.8M | ||
| Total Shareholder Equity | 68.1M | 49.3M | 83.4M | 38.8M | ||
| Share Information | Common Shares Outstanding | 25.4M | 25.4M | 24.6M | 24.7M | |
| Addtl. Info. | No data currently available for this section. | |||||
